Niagen Bioscience (NAGE) Shares Outstanding (2011 - 2026)

Niagen Bioscience (NAGE) has 15 years of Shares Outstanding (Entity) data on file, last reported at $79.5 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.31% year-over-year to $79.5 million in Q1 2026; TTM through Mar 2026 was $79.5 million, a 1.31% increase from a year earlier, with the FY2025 full-year figure at $79.7 million, up 3.08% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $79.5 million, roughly flat from $79.7 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for NAGE reached as high as $79.7 million in Q4 2025 and fell as low as $68.1 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $75.3 million across 5 years, with a median of $75.2 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) rose 0.11% in 2022 and gained 9.89% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $74.6 million in 2022, then advanced by 0.56% to $75.0 million in 2023, then grew by 3.13% to $77.3 million in 2024, then grew by 3.08% to $79.7 million in 2025, then decreased by 0.32% to $79.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $79.5 million in Q1 2026, $79.7 million in Q4 2025, and $79.6 million in Q3 2025.